| NCT05126758 | A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-06-22 | 2027-12 | 2025-12 |
| NCT04623671 | Intravenous Infusion of CAP-1002 in Patients With COVID-19 | COMPLETED | PHASE2 | 2020-11-15 | 2022-02-04 | 2022-02-04 |
| NCT04428476 | Open-label Extension of the HOPE-2 Trial | ACTIVE_NOT_RECRUITING | PHASE2 | 2020-08-05 | 2026-03 | 2022-02-16 |
| NCT06304064 | Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) | COMPLETED | PHASE2 | 2018-06-21 | 2019-03-06 | 2019-03-06 |
| NCT03406780 | A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy | COMPLETED | PHASE2 | 2018-04-04 | 2020-03-10 | 2020-03-10 |
| NCT02485938 | HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) | COMPLETED | PHASE2 | 2016-01-07 | 2017-09-14 | 2017-09-14 |
| NCT02603614 | Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment | COMPLETED | PHASE1, PHASE2 | 2015-12 | 2016-03-31 | 2016-03-31 |
| NCT02359227 | Safety Study of Cenderitide in Stable Chronic Heart Failure | COMPLETED | PHASE2 | 2015-01 | 2015-04-02 | 2015-04-02 |
| NCT02293603 | Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) | UNKNOWN | PHASE1 | 2014-11 | 2020-04 | 2015-05 |
| NCT01458405 | Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration | TERMINATED | PHASE1, PHASE2 | 2012-11-13 | 2019-02-28 | 2017-07-03 |